Can a Newly Developed Drug Cure a Common, Yet Little Known, STI?
August 29, 2024
August 29, 2024
NEW ORLEANS, Louisiana, Aug. 29 (TNSres) -- Tulane University issued the following news release:
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
The five-year, multi-center study is funded by a $9.2 million National Institutes of Health grant and will compare . . .
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
The five-year, multi-center study is funded by a $9.2 million National Institutes of Health grant and will compare . . .